CIBC Private Wealth Group
XBI icon

CIBC Private Wealth Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CIBC Private Wealth Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.83M Buy
23,217
+5,329
+30% +$611K ﹤0.01% 517
2025
Q3 		$1.79M Sell
17,888
-2,441
-12% -$220K ﹤0.01% 592
2025
Q2 		$1.69M Sell
20,329
-600
-3% -$47.9K ﹤0.01% 582
2025
Q1 		$1.46M Buy
20,929
+1,473
+8% +$132K ﹤0.01% 592
2024
Q4 		$1.8M Buy
19,456
+5,117
+36% +$496K ﹤0.01% 592
2024
Q3 		$1.42M Buy
14,339
+7,929
+124% +$779K ﹤0.01% 631
2024
Q2 		$598K Buy
6,410
+2,815
+78% +$252K ﹤0.01% 775
2024
Q1 		$337K Buy
+3,595
New +$334K ﹤0.01% 935
2022
Q4 		– Sell
-10,053
Closed -$798K – 952
2022
Q3 		$798K Sell
10,053
-2,899
-22% -$244K ﹤0.01% 634
2022
Q2 		$962K Buy
12,952
+9,733
+302% +$731K ﹤0.01% 600
2022
Q1 		$290K Buy
3,219
+160
+5% +$14.8K ﹤0.01% 856
2021
Q4 		$342K Hold
3,059
– – ﹤0.01% 845
2021
Q3 		$385K Sell
3,059
-5,653
-65% -$728K ﹤0.01% 775
2021
Q2 		$1.18M Buy
8,712
+2,280
+35% +$300K ﹤0.01% 630
2021
Q1 		$872K Buy
6,432
+116
+2% +$17.4K ﹤0.01% 695
2020
Q4 		$889K Sell
6,316
-418
-6% -$53.5K ﹤0.01% 656
2020
Q3 		$750K Buy
+6,734
New +$755K ﹤0.01% 612
2020
Q2 		– Sell
-2,644
Closed -$205K – 829
2020
Q1 		$205K Sell
2,644
-65
-2% -$5.76K ﹤0.01% 798
2019
Q4 		$258K Sell
2,709
-571
-17% -$49.4K ﹤0.01% 828
2019
Q3 		$250K Sell
3,280
-63
-2% -$5.24K ﹤0.01% 818
2019
Q2 		$293K Sell
3,343
-1,079
-24% -$92K ﹤0.01% 822
2019
Q1 		$400K Buy
4,422
+804
+22% +$68.4K ﹤0.01% 766
2018
Q4 		$260K Buy
3,618
+300
+9% +$24.2K ﹤0.01% 793
2018
Q3 		$318K Buy
3,318
+448
+16% +$43.4K ﹤0.01% 853
2018
Q2 		$273K Buy
2,870
+72
+3% +$6.62K ﹤0.01% 869
2018
Q1 		$245K Sell
2,798
-50
-2% -$4.57K ﹤0.01% 903
2017
Q4 		$242K Sell
2,848
-43
-1% -$3.6K ﹤0.01% 906
2017
Q3 		$250K Buy
+2,891
New +$232K ﹤0.01% 869

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

CIBC Private Wealth Group's XBI Position: Q4 2025 in Review

CIBC Private Wealth Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 30% in Q4 2025, buying an estimated $611K and bringing the position to 23,217 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #517.

CIBC Private Wealth Group first reported a position in XBI in Q3 2017 and has held it in 28 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

  • CIBC Private Wealth Group held 23,217 shares of State Street SPDR S&P Biotech ETF worth $2.83M as of Q4 2025.
  • CIBC Private Wealth Group bought 5,329 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $611K.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #517 holding.
  • CIBC Private Wealth Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and has held it in 28 quarters since.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.